Trial Number


Age range

18 Years to 90 Years


Male or Female

Enrolling Patients


A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System. The CAPERE™ Thrombectomy System is designed to achieve clot retrieval with one (1) treatment session. The CAPERE™ system is cleared for market in the United States and this study is intended to capture real-world clinical data as part of CAPERE™ post-market clinical follow up.

Principal Investigator

MemorialCare Research Center Contact Form

For further information about this study or to express your interest in this study, please fill out and submit this form.

Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.